InspireMD, Inc. (NSPR) is a publicly traded Healthcare sector company. As of November 11, 2026, NSPR trades at $0.80 with a market cap of $36.53M and a P/E ratio of -0.79. NSPR moved +3.31% today. Year to date, NSPR is -58.60%; over the trailing twelve months it is -50.98%. Its 52-week range spans $0.43 to $2.93. Analyst consensus is buy with an average price target of $3.50. Rallies surfaces NSPR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for NSPR, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.80 |
| Market Cap | $36.53M |
| P/E Ratio | -0.79 |
| EPS | $-0.62 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.93 |
| 52-Week Low | $0.43 |
| Volume | 246.95K |
| Avg Volume | 0 |
| Revenue (TTM) | $10.84M |
| Net Income | $-52.48M |
| Gross Margin | 18.05% |
2 analysts cover NSPR: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.50.